Although the intestine plays the major role in 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] action on calcium homeostasis, the mechanisms involved remain incompletely understood. The established model of 1,25(OH) 2 D 3 -regulated intestinal calcium absorption postulates a critical role for the duodenum. However, the distal intestine is where 70% to 80% of ingested calcium is absorbed. To test directly the role of 1,25(OH) 2 D 3 and the vitamin D receptor (VDR) in the distal intestine, three independent knockout (KO)/transgenic (TG) lines expressing VDR exclusively in the ileum, cecum, and colon were generated by breeding VDR KO mice with TG mice expressing human VDR (hVDR) under the control of the 9.5-kb caudal type homeobox 2 promoter. Mice from one TG line (KO/TG3) showed low VDR expression in the distal intestine (,50% of the levels observed in KO/TG1, KO/TG2, and wild-type mice). In the KO/TG mice, hVDR was not expressed in the duodenum, jejunum, kidney, or other tissues. Growth arrest, elevated parathyroid hormone level, and hypocalcemia of the VDR KO mice were prevented in mice from KO/TG lines 1 and 2. Microcomputed tomography analysis revealed that the expression of hVDR in the distal intestine of KO/TG1 and KO/TG2 mice rescued the bone defects associated with systemic VDR deficiency, including growth plate abnormalities and altered trabecular and cortical parameters. KO/TG3 mice showed rickets, but less severely than VDR KO mice. These findings show that expression of VDR exclusively in the distal intestine can prevent abnormalities in calcium homeostasis and bone mineralization associated with systemic VDR deficiency. (Endocrinology 158: 3792-3804, 2017) T he principal action of 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] and the vitamin D receptor (VDR) is intestinal calcium absorption (1-5). The proposed model indicates that calcium enters the enterocyte through the epithelial calcium channel transient receptor potential vanilloid type 6 (TRPV6) and then binds to the calciumbinding protein calbindin (1, 2). At the basolateral membrane, calcium is transported by the plasma membrane calcium pump into the extracellular space (1, 2).
T he principal action of 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] and the vitamin D receptor (VDR) is intestinal calcium absorption (1) (2) (3) (4) (5) . The proposed model indicates that calcium enters the enterocyte through the epithelial calcium channel transient receptor potential vanilloid type 6 (TRPV6) and then binds to the calciumbinding protein calbindin (1, 2) . At the basolateral membrane, calcium is transported by the plasma membrane calcium pump into the extracellular space (1, 2) .
The duodenum has been a focus of research related to this 1,25(OH) 2 D 3 -regulated calcium absorptive process (6) . However, the distal intestinal is where 70% to 80% of ingested calcium is absorbed (7) . VDR, calbindin-D 9k , and TRPV6 are expressed in all segments of the small and large intestine (5, (8) (9) (10) (11) (12) . The highest levels of TRPV6 are in the cecum and colon (12) . 1,25(OH) 2 D 3 regulation of active calcium absorption has been reported in the ileum, cecum, and colon (13) (14) (15) (16) . In addition, the distal intestine as well as the duodenum are responsive to 1,25(OH) 2 D 3 , and early studies suggested that the distal intestine plays a major role in adaptation to low dietary calcium (10, 15, 17) . Furthermore, studies in patients with extensive resection of the small intestine reported that calcium absorption was higher when the colon was preserved (18) .
Although these findings indicate that the distal segments of the intestine in addition to the duodenum play an important role in 1,25(OH) 2 D 3 -mediated calcium homeostasis, very little is known about 1,25(OH) 2 D 3 action in the distal intestine. Although it has been a matter of debate, in the current study we provide evidence that transgenic (TG) expression of VDR exclusively in the distal intestine can prevent abnormalities in calcium homeostasis and bone mineralization associated with systemic VDR deficiency. These findings have important implications regarding how regional bowel disease may disrupt calcium homeostasis and the impact of gastric bypass surgery on distal intestinal calcium absorption.
Materials and Methods

Materials
Polyvinylidene difluoride membranes and prestained markers were obtained from Bio-Rad Laboratories (Hercules, CA). The enhanced chemiluminescent detection system was purchased from Denville Scientific (Holliston, Plasmids pBSKS-CDX2 (caudal type homeobox 2) 9.5-kb promoter region (CDX2P 9.5) plasmid was a kind gift from Dr. E. Fearon (University of Michigan Medical School). The pcDNA3.1-hVDR plasmid encoding amino acid residues 4 to 427 of the human vitamin D receptor (hVDR) was provided by Dr. P. McDonald (Case Western Reserve University). A poly(A) region containing pL3 plasmid was purchased from Addgene (Cambridge, MA). All restriction and modification enzymes were obtained from New England BioLabs, Inc.
Generation of distal intestine2specific hVDR-expressing TG mice
The transgene was constructed in the pBSKS-9.5kb CDX2 plasmid. The 9.5-kb fragment from the CDX2 proximal promoter region was shown to direct transgene expression specifically in the distal ileum, the cecum, and the colon (19) . The hVDR fragment from the pcDNA3.1 hVDR plasmid was subcloned together with a polyadenylation cassette into the EcoRI and HindIII sites, respectively, of the pBSKS-9.5kb CDX2 plasmid to generate the pBSKS-9.5kb CDX2-hVDR poly(A) plasmid. Restriction digestion analysis and sequencing confirmed the presence and correct orientation of hVDR. The pBSKS-9.5kb CDX2-hVDR poly(A) plasmid was tested in vitro for VDR protein expression by transfection (using lipofectamine 2000) in Caco-2 cells grown in medium and conditions as previously described (20) , followed by hVDR Western blot analysis (21) . The 9.5-kb CDX2-hVDR poly(A) transgene was isolated from vector sequences and injected into pronuclei of fertilized FVB/N mouse oocytes at the Rutgers New Jersey Medical School Genome Editing Core Facility. Founders were identified using DNA extracted from tail biopsies by polymerase chain reaction (PCR) with hVDR-specific primers that do not recognize mouse VDR (5 0 613 -635; 3 0 1020 -999). TG mice were backcrossed to the C56BL/6J background for multiple generations (eight or greater). TG mice with high or low hVDR expression were mated to VDR knockout (KO) mice [male VDR KO mice fed a calcium/lactose rescue diet (3) were used for breeding; VDR KO mice are on the C57BL/6 background and were obtained from The Jackson Laboratory (originally from M. Demay, Harvard Medical School). Offspring heterozygous for transgene integration and for ablation of the endogenous receptor (TG +/2 , KO +/2 ) were bred to obtain mice with intestine-specific TG expression (TG/KO mice). Genotyping was done using mouse-and human-specific VDR primers. Mice were maintained in a virus-and parasite-free barrier facility and exposed to a 12-hour light, 12-hour dark cycle. Food and water were given ad libitum. All animal experiments were approved by the Rutgers New Jersey Medical School Animal Care and Use Committee.
Characterization of TG mice expressing hVDR in the distal intestine
Mice were fed a standard rodent chow diet (Rodent Laboratory Chow 5001; Ralston Purina Co.) ad libitum from birth. Eight-to 9-week-old mice were used for initial characterization studies. In other studies, including those related to the skeletal phenotype, 10-to 12-week-old mice were used. Both male and female mice were studied. No sexual dimorphism was observed in the vitamin D target genes or proteins examined at these ages. Blood was collected, and serum was prepared for analysis of calcium using atomic absorption spectrometry (22) with a standard calcium chloride solution (Thermo Fisher Scientific) and parathyroid hormone using the two-site immunoradiometric assay (Immutopics, Clemente, CA). Levels of osteocalcin were measured by radioimmunoassay as previously described (23) . Tissues were harvested, and RNA and protein were isolated. Tibiae were harvested for histology and for the assessment of microarchitecture using microcomputed tomography (micro-CT) and histomorphometry. In studies examining the response to 1,25(OH) 2 D 3 treatment, mice were injected intraperitoneally with either vehicle or 1,25(OH) 2 D 3 three times over 48 hours (48, 24 , and 6 hours before being euthanized: 100 ng/100 g of body weight in 0.1 mL of a 9:1 mix of propylene glycol and ethanol) before termination. The three-dose protocol was used to study both short-term and long-term effects of 1,25(OH) 2 D 3 administration.
RNA isolation and analysis
Total RNA was isolated after disruption of the tissues using RiboZol RNA extraction reagent from Amresco, Inc. (Solon, OH). Reverse transcription PCR (RT-PCR) was performed using 2 mg of total RNA, the Superscript TM One-Step RT-PCR System with Platinum Taq DNA polymerase (Thermo Fisher Scientific, Inc.), and specific human or mouse VDR primers (Supplemental Table 1 ). The resulting PCR products were subjected to electrophoresis on a 1% agarose gel containing ethidium bromide, and bands were visualized under UV light. Gel data were recorded using the Gene Genius bioImaging System (Syngene, Frederick, MD), and relative densities of the bands were determined using Gene Tool Software (Syngene). b-Actin messenger RNA (mRNA) was used as a control. For each primer set, PCR cycle numbers were chosen so that the amplification was in the linear range of amplification efficiency. In addition, quantitative real-time PCR (qRT-PCR) was used to quantify hVDR mRNA and Cyp24a1 and Trpv6 mRNAs in the mouse intestine using Taqman analyses. TaqMan Gene Expression probes (Applied Biosystems, Foster City, CA) were used for qRT-PCR and are found in Supplemental Table 1 . Expression of the gene of interest was normalized to the expression of glyceraldehyde 3-phosphate dehydrogenase, and the 2 -DDCt method was used to calculate relative gene expression. All qRT-PCR reactions were performed in triplicate.
Western blot analysis
Tissue harvested from the animals was rinsed in ice-cold phosphate-buffered saline containing a protease inhibitor cocktail, frozen in liquid nitrogen, and stored at 280°C or used immediately. For Western blot analysis of calbindin-D 9k , postmitochondrial supernatants were prepared. For Western blot analysis of VDR, total cellular protein was prepared using a lysis buffer containing 50 mM of Tris-HCl (pH, 7.5), 150 mM of NaCl, 0.1% sodium dodecyl sulfate, 1.0% NP-40, and protease inhibitors. After centrifugation, the protein content of the supernatants was measured by the Bradford method (24) or by using the Reducing Agent and Detergent Compatible Protein Assay (Bio-Rad Laboratories, Inc., Hercules, CA), divided into 50-mg aliquots, and stored at 280°C until used. Using an enhanced chemiluminescent detection system (Denville Scientific, Inc., Holliston, MA), 50 mg of denatured protein was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes for Western blot analysis. Ponceau S staining (intestine) or b-actin (kidney) immunoblotting was used to normalize for sample variation.
Bone analysis
Changes in bone mineralization were examined by micro-CT and histomorphometry as previously described (25) . Micro-CT analysis of the left tibiae was performed ex vivo using a highresolution SkyScan 1172 system to examine trabecular and cortical bone volume and parameters (trabecular volume, trabecular number, trabecular thickness, and cortical porosity). For histology, sections were stained according to von Kossa or Goldner to assess mineralized bone and unmineralized bone matrix, respectively. Histomorphometric analysis was performed on (un)decalcified tibiae sections as described (26) . Appearance of the growth plate, trabecular mineralized bone volume, osteoid abundance, osteoblast and osteoclast numbers, and dynamic bone parameters were determined using a Zeiss Axiovert microscope and AxioVision imaging analyzing system and was expressed according to the American Society for Bone and Mineral Research standardized histomorphometry nomenclature (27) .
Statistical analysis
Results are expressed as mean 6 standard error (standard error of the mean). Normal distribution of the data was confirmed with the Shapiro-Wilk normality test. To test differences between different genotypes, we applied one-or two-way analysis of variance or the Student t test for two-group comparison, as indicated in the figure legends. Differences were considered significant at P , 0.05.
Results
Generation and characterization of distal intestine2specific hVDR TG mice
To test directly in vivo the role of distal intestinal segments in the biological actions of 1,25(OH) 2 D 3 , TG mice expressing hVDR exclusively in the ileum, cecum, and colon were generated. Full-length hVDR complementary DNA was subcloned together with a polyadenylation cassette into EcoRI and HindIII sites, respectively, of the pBSKS-9.5kb CDX2 plasmid [ Fig.  1(a) ]; the 9.5-kb fragment of the CDX2 promoter was previously reported to direct transgene expression specifically in the distal ileum, the cecum, and the colon (20) . The resulting pBSKS-9.5kb CDX2-hVDR poly(A) plasmid was first tested in vitro for VDR protein expression by transfection in Caco-2 cells. Western blot analysis indicated strong expression of the VDR protein in Caco-2 cells using the transgene construct (not shown). This construct was injected into the pronucleus of wild-type (WT) mouse oocytes, and three founders were identified [ Fig. 1(b) ]. The founders were mated to VDR KO mice, and VDR KO mice expressing hVDR specifically in the distal intestine were generated. shows the expression of hVDR mRNA in KO/TG mice (low levels in the ileum, higher levels in the cecum and colon). hVDR mRNA was not observed in WT or VDR KO mice. Quantitative analysis of hVDR mRNA expression indicated that the highest expression of the transgene was observed in the cecum and colon (compared with the ileum) in all three TG lines [ Fig. 2(a) , right panel]. Mice from KO/TG line 3 showed low hVDR mRNA levels in the distal intestine compared with levels in KO/TG1 and KO/TG2 mice [ Fig. 2(a), right panel] . Western blot analysis indicated that VDR protein was undetectable in the duodenum and jejunum in all three TG lines [ Fig. 2(b) ]. Levels of VDR in the cecum and colon of KO/TG1 and KO/TG2 mice and WT mice were equivalent [ Fig. 2(b) ]. VDR protein could be detected in the ileum of the KO/TG mice when the protein concentration was increased (not shown). KO/TG3 mice expressed ,50% of the levels of VDR protein observed in KO/TG1 and KO/TG2 mice and WT mice [ Fig. 2(b) ]. Note that in Fig. 2(c) hVDR mRNA was expressed only in the ileum, cecum, and colon. hVDR mRNA was not expressed in other parts of the intestine and in other organs and tissues in KO/TG mice (in the 2-and 3-monthold mice examined). Similar results were observed for all three KO/TG lines.
The growth arrest and decreased body weight of the VDR KO mice were prevented in mice from KO/TG lines 1 and 2 but not in mice from KO/TG line 3 [ Fig. 3(a)2  3(c) ]. Progressive hair loss was observed in all three KO/ TG lines, similar to loss in VDR KO mice. Alopecia was progressive and was more pronounced after 2 months of age (not shown). Elevated serum parathyroid hormone (PTH) levels observed in the VDR KO mice were reduced to values seen in WT mice in KO/TG1 and KO/TG2 mice [ Fig. 3(d), left panel] . Serum PTH levels remained elevated in KO/TG3 mice but were significantly lower than 
Skeletal phenotype
Histological analysis of the growth plate showed that the rachitic phenotype of VDR KO mice was prevented in mice from KO/TG lines 1 and 2 but not in mice from KO/ TG line 3 [ Fig. 5(a) ]. Growth plate width was increased compared with that of WT in VDR KO mice and in mice from KO/TG line 3 but not in mice from KO/TG lines 1 and 2 [ Fig. 5(a) and 5(b) ]. Micro-CT analysis of the mineralized bone revealed that the abnormal trabecular bone volume and decreased cortical thickness associated with systemic VDR deficiency were rescued in mice from KO/TG lines 1 and 2 [ Fig. 6(a) ]. The trabecular and cortical abnormalities observed in the VDR KO mice were not rescued in mice from KO/TG line 3 [ Fig. 6(a) ]. Prevention of the altered trabecular and cortical parameters was further confirmed by von Kossa staining of histological sections of the tibia [ Fig. 6(b) ]. Goldner staining done to assess unmineralized bone matrix also indicated that mice from KO/TG lines 1 and 2 had amounts of unmineralized bone matrix similar to that of WT mice and that mice from KO/TG line 3 still showed signs of osteomalacia (but less severe than that of VDR KO mice) [ Fig. 7(a) ]. As shown in Fig. 7 (b) and 7(c), the increases in osteoid surface and osteoid thickness observed in VDR KO mice were restored to the levels of WT mice in KO/TG lines 1 and 2. Serum osteocalcin levels were increased in VDR KO and KO/TG3 mice (174.4 6 10.8 and 176.2 6 24.9 ng/mL, respectively) compared with the level in WT mice (87.6 6 19.9 ng/mL; P , 0.05) in accordance with the more pronounced presence of unmineralized bone matrix in VDR KO and KO/TG3 mice. Levels of serum osteocalcin in KO/TG1 and KO/TG2 mice (73.1 6 8 and 69.0 6 7.4 ng/mL, respectively) were not significantly different from that of WT mice (P . 0.1) (n = five mice per genotype).
Discussion
Although vitamin D is the major factor controlling intestinal calcium absorption and the duodenum has been the major focus of research, the mechanisms involved and the relative contribution of different segments of the intestinal tract to 1,25(OH) 2 D 3 2mediated calcium absorption remain incompletely understood. In this study, we showed that TG expression of VDR exclusively in the distal intestine can prevent abnormalities in calcium homeostasis and bone mineralization associated with systemic VDR deficiency.
Previous studies noted that the principal function of vitamin D/VDR in maintaining calcium homeostasis is to increase calcium absorption from the intestine. This conclusion was made from studies in VDR-null mice that showed that rickets, osteomalacia, and hypocalcemia were prevented when the VDR-null mice were fed a rescue diet that included high calcium (2%) (3, 4) . Subsequent findings from Xue and Fleet (5) showed that TG expression of VDR in the entire intestine of VDR-null mice was sufficient to prevent rickets and normalize serum calcium levels, providing direct evidence of the importance of VDR in intestinal calcium absorption.
An important consideration that has been a matter of debate is the relative contribution of the proximal vs the distal intestine to VDR-mediated intestinal calcium absorption. Early studies by Pansu et al. (28) reported that active transcellular calcium transport was completely dependent on vitamin D and was localized to the duodenum. This is in contrast to studies that demonstrated that a low calcium diet [which results in increased synthesis of 1,25(OH) 2 D 3 ] caused an increase in saturable mucosal to serosal Ca 2+ influx in the ileum with little effect on the paracellular pathway (29, 30) . Studies using everted sacs also noted a significant increase in active transport in the ileum in response to 1,25(OH) 2 D 3 in 1,25(OH) 2 D 3 -deficient young rats (31) . Calbindin-D 9k and the calcium pump are induced by 1,25(OH) 2 D 3 in the ileum (10, 17, 32) . The capacity of the ileum (as well as the cecum) in deficient animals to respond to 1,25(OH) 2 D 3 as measured by an increase in calbindin-D 9k was reported to be greater than that of the duodenum (10, 17) . We also noted 1,25(OH) 2 D 3 -mediated induction of calbindin-D 9k in the ileum (as well as in the cecum and colon), with TG expression of VDR in the distal intestine of VDR KO mice. However, similar to our findings, previous studies reported that TRPV6 mRNA was not detected in the ileum and that TRPV6 protein was CYP24a1 mRNA was not detectable in untreated mice. Trpv6 mRNA was detected in low levels in KO/TG mice in the duodenum but expressed at very low levels in the ileum and the proximal jejunum (12, 33) . It has been suggested that low levels of TRPV6 in the ileum contribute to the slow rate of calcium transport in this intestinal segment compared with other segments (7).
Unlike the ileum, which transports calcium at a relatively slow rate, the cecum has been reported to have the highest rate of calcium transport compared with other intestinal segments (34) . Nevertheless, the contribution of the cecum to total calcium absorption has been a matter of debate (35, 36) . The physiological significance of the cecum for body calcium homeostasis was recently noted in studies in cecectomized rats, which showed significant cortical and trabecular bone loss (37) . Active calcium transport and calbindin-D 9k and TRPV6 mRNAs were enhanced in the colon but not in the duodenum, jejunum, or ileum of the cecectomized rats, suggesting compensation in the lower bowel but not the proximal intestine (37) .
In studies using isolated rat intestinal segments, 1,25(OH) 2 D 3 was reported to stimulate active calcium transport in the cecum and colon (14, 15) . 1,25(OH) 2 D 3 has also been reported to enhance calcium absorption in the colon of healthy humans (38) . In our study, both calbindin-D 9k and TRPV6 mRNA were present in the cecum as well as in the colon and were induced by 1,25(OH) 2 D 3 . A limitation of our study at this time is a lack of direct measurement of calcium absorption in the individual intestinal segments. Nevertheless, our findings show that TG expression of VDR restricted to the distal ileum, cecum, and colon of VDR KO mice rescued VDRdependent rickets and normalized serum calcium levels and that the distal intestine was sensitive to 1,25(OH) 2 D 3 as indicated by induction of vitamin D target genes. These findings are consistent with the major role of 1,25(OH) 2 D 3 2mediated calcium absorption in the distal intestine for the maintenance of calcium homeostasis.
In our study, we found that the degree of rescue of the bone phenotype was dependent on the level of VDR expressed in the distal intestine. Previous in vivo and in vitro studies noted that changes in VDR levels in (39) (40) (41) . Deletion of VDR specifically from all segments of the intestine (Vdr int2 mice) resulted in a marked decrease in bone mass, with spontaneous bone fractures frequently observed (26) . However, in the Vdr int2 mice, the serum calcium level was normal because of the presence of VDR in other tissues and therefore increased renal calcium reabsorption, increased bone resorption, and inhibition of calcium incorporation into bone mediated by 1,25(OH) 2 D 3 (26) . When VDR is deleted specifically from the caudal region of the mouse intestine, altered calcium metabolism is also observed. In mice that lack VDR in the large intestine, there is a modest decrease in femoral bone density, a decrease in TRPV6 and calbindin-D 9k mRNAs in the distal intestine, a compensatory increase in the expression of these genes in the duodenum, and normal serum calcium levels (42) . Together, these findings and our results indicate that intestinal VDR, including VDR in the caudal region of the intestine, is essential for normal bone homeostasis. Further studies using our mouse model are needed to identify the contribution of individual segments of the distal intestine to VDR-mediated calcium homeostasis and to determine whether different as well as similar targets are contributing to calcium absorption in proximal vs distal intestinal segments.
In addition to using an active transcellular process, intestinal calcium absorption also occurs by a passive nonsaturable process. Absorption by passive diffusion has been reported to occur through tight junctions and intercellular spaces and to predominate in the distal region of the intestine when dietary calcium is adequate or high (7) . There are conflicting data, however, related to the vitamin D dependency of paracellular intestinal calcium transport. Early in vivo studies showed that both active and passive nonsaturable processes were enhanced by vitamin D (43, 44) . However, studies by Pansu et al. (28, 45) reported that the paracellular process was independent of vitamin D. More recent studies have shown that 1,25(OH) 2 D 3 can regulate proteins involved in tight junction complexes (claudin-2 and -12) and cadherin-17 (a cell adhesion protein important for cell-to-cell contact) in the intestine (46-50). Thus, it is possible that normalization of serum calcium due to TG expression of VDR in the distal intestine may involve in part VDR regulation of the paracellular as well as the transcellular pathway. However, further studies are needed to determine the role of these intercellular adhesion molecules in intestinal physiology and whether their regulation by 1,25(OH) 2 D 3 is related to intestinal calcium absorption. In a recent report, it was noted that under conditions of dietary calcium restriction, intestinal calcium absorption correlated to TRPV6, calbindin-D 9k , and PMCA1b mRNAs (the traditional transcellular mediators) but not to the expression of claudin-2 or claudin-12 mRNA (51). Thus, as previously suggested, multiple factors yet to be identified are involved in VDR-mediated intestinal calcium absorption (52) .
Although studies examining both active and passive transport in individual intestinal segments are needed, our findings showing a correlation between increased serum calcium in the TG/KO mice and induction of TRPV6 mRNA and calbindin-D 9k suggest that active transport is involved in the rescue of VDR-dependent rickets by VDR expression in the distal intestine.
In summary, our data show the importance of the distal intestinal segments in vitamin D2mediated calcium homeostasis and bone mineralization. Gastric bypass surgery has resulted in a number of complications in patients, including malabsorption of calcium and decreased bone mineral density (53) (54) (55) . Animal studies have also noted gastric bypass2associated bone resorption (56, 57) . Future studies related to mechanisms involved in VDR-mediated activation of calcium absorption in the distal intestine may suggest new strategies involving the distal intestine that can compensate for calcium malabsorption and increase the efficiency of intestinal calcium uptake to minimize bone loss due to bariatric surgery or small bowel resection. Our findings also have implications for enhancement of calcium absorption in other individuals at risk for bone loss, including patients with inflammatory bowel disease and those with reduced calcium absorption after menopause or due to aging.
